Treatment effect of switching from salmeterol/fluticasone to formoterol/budesonide combinations in patients with asthma
Not Applicable
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000009619
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
History of hypersensitivity to budesonide and formoterol History or presence of lung, cardiac, renal and liver desease Use of systemic corticosteroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CaNO at week 0 and week 12
- Secondary Outcome Measures
Name Time Method J'awNO at week 0 and week 12 FeNO at week 0 and week 12 FEF75 at week 0 and week 12 FEF50 at week 0 and week 12 FVC at week 0 and week 12 Adverse events at week 0 and week 12 Mean rate of all exacerbations at week 0 and week 12